ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.85
0.00 (0.00%)
Last Updated: 08:00:04
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.85 4.70 5.00 4.95 4.85 4.95 0.00 08:00:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.55 25.87M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.85p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £25.87 million. Eden Research has a price to earnings ratio (PE ratio) of -11.55.

Eden Research Share Discussion Threads

Showing 6676 to 6697 of 17800 messages
Chat Pages: Latest  268  267  266  265  264  263  262  261  260  259  258  257  Older
DateSubjectAuthorDiscuss
22/5/2019
10:31
Apathy by design imo.

The pertinent question is..Why..?

I have no doubt it's happening.. so it's intentional or they are foolish.

They are far from Foolish imo .

Nothing else makes sense to me.

My Answer is ..Please refer to Xinova ..this is Transformational tech with wide and widening applications with NDA firm lids.

AA Swedish Fridge magnet reminds him to ..Keep it Damp

supersonico
22/5/2019
10:05
Super,

Very nice comments, but...

When will the Company, as a listed Plc and with responsibilities to its shareholders, address the ongoing undervaluation of the business and put it on a proper footing!

You cannot be a Plc and ignore value. If the business strategy was wrong, you would do something about it. Indeed, Eden did so in relation to its pricing model.

If the share price is wrong, do something about it, perhaps before someone else does.

There appears to me to be total apathy around the share price and total acceptance all round that this will continue. Surely this is unacceptable.

investingisatrickygame
22/5/2019
07:58
Nothing to see Here..News. please move along..

From post 5607/ Michel VILLENEUVE

Also chipping in is Michel VILLENEUVE who knows a thing or deux.

Commercial Advisor EDENRESEARCH Plc UK, MICROCIDE Plc UK, Consultant FERTINAGRO Biotech SL Spain, AMC Malta, SIPCAM Esp

"Alex and Sean you are on the right tracks to grow Edenresearch on key markets with new rights to sell coming in 2019 and 2020".

…………...

Eden Research plc recently announced that is has appointed Mr. Michel Villeneuve as a Strategic Commercial Advisor.
Mr. Villeneuve has over thirty years' experience in a variety of senior commercial, regulatory and management roles with major multinational companies involved in plant protection (members of the CropLife organisation) including the leadership of businesses in various countries throughout Europe, Africa and the Middle East. Mr. Villeneuve also has extensive experience in advising high-growth companies in the Plant Protection Sector in markets including fungicides, nematicides and plant nutrients.
Mr. Villeneuve will be supporting Eden with strategy development and execution as well as strategic business development in a number of territories. His contributions are most welcome and add a significant amount of experience and energy to the team.

supersonico
21/5/2019
21:55
Loved the crusaders btw.
:)

brucie5
21/5/2019
21:23
Bayer2013?, Bayer2013 who?, never heard of them.
supersonico
21/5/2019
20:46
Super,

If you didn't know better you might assume Eden is Bayer's puppet

investingisatrickygame
21/5/2019
19:30
Investing ..it's all a bit odd. A bit like the proactive video which received such warm reviews from Bayer and De Sangosse bods.

Funnily enough it does not appear on the Eden Research Linked in Feed. At least I can't find it again..it's gone underground. Sorry to repeat myself but in these depressing times it's nice to know a few kind , well connected souls who work for multi Billion $$ companies are generous enough to comment on a Minnow which often has only one or two trades per day.

………………...

supersonico
24 Jan '19 - 22:58 - 5607 of 6325 Edit
0 0 0
Proactive @ Eden ….Audience feedback..

Nice to see Anne Williams Global Product Manager Tomato/ Biotechnology @ Monsanto-Bayer offer some kind words of support to Sean Smith and the Eden Team.

"Great news guys - clear focus and a lot of hard work looks like it’s paying off - Congratulations"

Also chipping in is Michel VILLENEUVE who knows a thing or deux.

Commercial Advisor EDENRESEARCH Plc UK, MICROCIDE Plc UK, Consultant FERTINAGRO Biotech SL Spain, AMC Malta, SIPCAM Esp

"Alex and Sean you are on the right tracks to grow Edenresearch on key markets with new rights to sell coming in 2019 and 2020".



We even have a Consultant fella Olivier Grosjean Consultant Expert AGRICULTURE from De Sangosse nodding in agreement .

De Sangosse is a European leader in Adjuvant technology, Nutrition, Molluscicides and Pod sealants helping growers protect their crops







From SANGOSSE #PositiveProduction "everywhere, we battalions face the majors, large multinational groups; But, thanks to our innovative technologies, we are able to take a leading position on niche markets with high added value such as Biocontrol and Biostimulators "the company's original capitalist model, held mainly by Its employees, is a key asset in developing a successful acquisition strategy.

supersonico
21/5/2019
16:24
44,000 shares traded in the last 3 days. Eden is such a damp squib, as well as a massively undervalued one.
investingisatrickygame
21/5/2019
15:40
While you wait..some Southern Comfort..
supersonico
21/5/2019
13:58
3/4 of my life too, I should wonder...
brucie5
21/5/2019
12:57
3/4 0f 120days Cedroz approaching.
supersonico
20/5/2019
20:33
Thanks, Sortudo. I think US regulatory clearance on Cedroz and Mevalone, plus positive news from Bayer and TT will be difficult for the market to overlook. But maybe now a dull time till September.
brucie5
20/5/2019
09:56
Talking Tomatoes with graphic content.
supersonico
19/5/2019
21:51
brucie5, yes I went to the AGM but to be honest I didn't hear anything so relevant that we already don't know. Not in the short term... Mevalone and Eden/Bayer products should be launched in the US by the end of 2019 (hopefully). I spoke to Lykele & Sean afterwards and I think we might have some more label extensions to other products and novelty related to sustaine this year. Let's see; I'm just speculating as they didn't want to disclose anything hastily. Maybe due to the NDA? 2019/2020 will be key years, imo.
sortudo7
19/5/2019
21:26
Well that's 8/9 crops right there, including the tomato, which incidentally, figures quite prominently in their presentation imagery... I'm becoming fixated on tomatoes...
brucie5
19/5/2019
15:17
Not sure what you mean. It's difficult to be optimistic on almost any level atm, environmentally, politically, socially, internationally. Nationally.

So I think any act of creative and peaceful resistance, such against Monsanto, Trump, or the various Alex Jones inspired Conspiracy Theorists has got to be a Good Thing.

And I think EDEN, if it can just get its act together, should be tiny incy wincy part of a solution.

brucie5
19/5/2019
14:47
Brucie5,

I had you down as a cheerful optimist but now your in the crazy camp with me:)

supersonico
19/5/2019
14:18
Sortudo, did you make it to the AGM?

Re. Bayer, who knows. I'm hoping that it may have shocked them, and a few others out of their complacency around generic and monopolistic chemical solutions to food production.

brucie5
18/5/2019
20:20
Since Bayer bought Monsanto its share price has fallen around 50% due its product (Roundup) troubles in US. I wonder if that may affect Bayer & Eden partnership somehow and the launch of their products...
sortudo7
18/5/2019
18:56
Super,

Nice to see Anne Williams Global Product Manager Tomato/ Biotechnology @ Monsanto-Bayer offer some kind words of support to Sean Smith and the Eden Team.

"Great news guys - clear focus and a lot of hard work looks like it's paying off - Congratulations"

Intriguing that, isn't it!!!

investingisatrickygame
18/5/2019
17:53
The BOD hasn’t decided either. Not sure if they know anything past CSE Botany . The big question is will they give their new Hire any scope. Her CV suggests she is ready to open up Eden to flower with bid yellow petals in the plains
chrischas
18/5/2019
17:36
I'm suggesting that the cashcrop figures of $1,415,000 you refer to includes all Tomatoes. That will include Field grown tomatoes and Glass house grown tomatoes. As I understand it Cedroz will be used on the higher value Glass house portion of the tomato market.

I'm assuming Cedroz will not be commercially viable if applied to field grown tomatoes but could easily be talking Bananas.

My understanding is that Cedroz and Mevalone treat different symptoms so I'm not suggesting 'when you use one, you kill both.

supersonico
Chat Pages: Latest  268  267  266  265  264  263  262  261  260  259  258  257  Older

Your Recent History

Delayed Upgrade Clock